Mortality from angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers in people infected with COVID-19: a cohort study of 3.7 million people (Family Practice, 2022)

(untitled) - Dambha-Miller, H; Hinton, W; Wilcox, CR; Lemanska, A; Joy, M; Feher, M; Stuart, B; de Lusignan, S; Hippisley-Cox, J; Griffin, S